Joel Greenblatt acquired 12.8 Thousand Neogenomics shares worth $175 Thousand. That's 0.00% of their equity portfolio (1228th largest holding). The first Neogenomics trade was made in Q2 2016. Since then Joel Greenblatt bought shares five more times and sold shares on seven occasions. The investor's estimated purchase price is $203 Thousand, resulting in a loss of 14%.